CN203989290U - A kind of p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres syringe of Timing - Google Patents
A kind of p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres syringe of Timing Download PDFInfo
- Publication number
- CN203989290U CN203989290U CN201420318801.8U CN201420318801U CN203989290U CN 203989290 U CN203989290 U CN 203989290U CN 201420318801 U CN201420318801 U CN 201420318801U CN 203989290 U CN203989290 U CN 203989290U
- Authority
- CN
- China
- Prior art keywords
- trp
- syringe
- tyr
- glu
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
This utility model provides a kind of p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres syringe of Timing, comprise syringe, be arranged on piston and the piston rod being connected with piston in syringe, also comprise timer, described timer comprises timing chip, character display and timing button, battery.Described timer is dismountable to be arranged on syringe.The p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres syringe of a kind of Timing described in the utility model is by adopting timer to prevent degraded and the pollution of p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres behind Kaifeng; Timer is dismountable is simultaneously arranged on syringe, can facilitate reusing of timer, avoids causing the unnecessary wasting of resources.
Description
Technical field
This utility model relates to technical field of medical instruments, relates in particular to a kind of syringe.
Background technology
Goserelin is the analog of a kind of synthetic LHRH, can promote the release of sex gland hormones, effect is strong 50～100 times compared with the LHRH of human secretory, LH-RH analog is the most of receptor in conjunction with hypophysis LH-RH by competition, feedback suppresses the secretion of LH and FSH, thereby suppress the generation of ovarioestrogen, reach the OO therapeutical effect of Drug.
Goserelin is used for the treatment of carcinoma of prostate and menopause is front and the breast carcinoma of climacteric, and the principle of endometriosis is medicine castration.Because the generation of gonadal hormone releasing hormone is subject to the regulation and control of the LHRH that hypothalamus pulsed discharges, p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 and hypophysis LHRH receptors bind, cause receptor down-regulated, thereby inhibition lutein is down to level in menopause by estradiol.This medicine castration in breast cancer treatment field from once occurring having caused concern, all shortcomings of therapeutic modality itself that it can avoid operation, radiotherapy to bring completely, and the function inhibitory action of its ovary is reversible in certain degree.
By suppressing hypophysis release action, in the lutropin of interstitial cell, suppress testosterone and produce, make testosterone concentration in blood drop to castration level.This medicine castration is a primary treatment method of carcinoma of prostate, because there being good toleration to replace in the clinical practice bilateral orchidectomy of more than 50 year and oral estrogen treatment.
In prior art, p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres can be treated patient by the mode of injection conventionally, but p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres is easily caused to the degraded of p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres, microbiological contamination as surpassed certain time length standing time in syringe.The purpose of this utility model is to provide a kind of p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres syringe, accurately timing provides sample useful life in syringe, has prevented from the harm that causes to patient because of sustained-release micro-spheres degraded, microbiological contamination from having reduced risk.
Utility model content
For p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres in prior art, in syringe, as surpassed certain time length standing time, easily cause the deficiency of the degraded of p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres, microbiological contamination, the purpose of this utility model is to provide a kind of p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres syringe of Timing.
For achieving the above object, the technical solution adopted in the utility model is as follows:
A p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres syringe for Timing, comprises syringe, is arranged on piston and the piston rod being connected with piston in syringe, also comprises timer, and described timer comprises timing chip, character display and timing button, battery.
Described timer is dismountable to be arranged on syringe.
The beneficial effects of the utility model are: the p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres syringe of a kind of Timing described in the utility model is by adopting timer to prevent degraded and the pollution of p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres behind Kaifeng; Timer is dismountable is simultaneously arranged on syringe, can facilitate reusing of timer, avoids causing the unnecessary wasting of resources.
Accompanying drawing explanation
Below in conjunction with accompanying drawing, by the specific embodiment of the present utility model is described in detail, will make the technical solution of the utility model and other beneficial effect apparent.
In accompanying drawing,
Fig. 1 is the overall structure schematic diagram of an embodiment of the p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres syringe of a kind of Timing described in the utility model.
Drawing reference numeral: 1, syringe; 2, piston; 3, piston rod; 4, timer;
41, timing chip; 42, character display; 43, timing button; 44|, battery.
The specific embodiment
Technological means and the effect thereof for further setting forth this utility model, taked, be described in detail below in conjunction with preferred embodiment of the present utility model and accompanying drawing thereof.
Consult Fig. 1, this utility model provides a kind of p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres syringe of Timing, comprise syringe 1, be arranged on piston 2 and the piston rod 3 being connected with piston 2 in syringe 1, also comprise timer 4, described timer 4 comprises timing chip 41, character display 42 and timing button 43, battery 44.
Dismountable being arranged on syringe of described timer 4.
Described in the present embodiment, a kind of p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres syringe of Timing is by adopting timer to prevent degraded and the pollution of p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres behind Kaifeng; Timer is dismountable is simultaneously arranged on syringe, can facilitate reusing of timer, avoids causing the unnecessary wasting of resources.
The above; for the person of ordinary skill of the art; can make other various corresponding changes and distortion according to the technical solution of the utility model and technical conceive, and all these changes and distortion all should belong to the protection domain of this utility model claim.
Claims (2)
1. the p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres syringe of a Timing, comprise syringe, be arranged on piston and the piston rod being connected with piston in syringe, it is characterized in that, also comprise timer, described timer comprises timing chip, character display and timing button, battery.
2. the p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres syringe of a kind of Timing according to claim 1, is characterized in that, described timer is dismountable to be arranged on syringe.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420318801.8U CN203989290U (en) | 2014-06-16 | 2014-06-16 | A kind of p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres syringe of Timing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420318801.8U CN203989290U (en) | 2014-06-16 | 2014-06-16 | A kind of p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres syringe of Timing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN203989290U true CN203989290U (en) | 2014-12-10 |
Family
ID=52029374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201420318801.8U Active CN203989290U (en) | 2014-06-16 | 2014-06-16 | A kind of p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres syringe of Timing |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN203989290U (en) |
-
2014
- 2014-06-16 CN CN201420318801.8U patent/CN203989290U/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU20130019A7 (en) | RECOMBINANT HUMAN FOLICULATING HORMONE, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS | |
| MX2013000125A (en) | Preservative-free follicle stimulating hormone solution delivery device. | |
| Richard | Endocrine therapy for breast cancer | |
| CN203989290U (en) | A kind of p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres syringe of Timing | |
| CN203989291U (en) | A kind of vibratile p-GLU-HIS-TRP-SER-TYR-D-TRP-LEU-ARG-PRO-GLY-NH2 sustained-release micro-spheres syringe | |
| Knobil | The wisdom of the body revisited | |
| RU2010102489A (en) | METHOD FOR PREDICTING PREGNANCY IN A PROGRAM OF EXTRACORPORAL FERTILIZATION AND TRANSFER OF EMBRYONS IN THE STANDARD LONG LONG PROTOCOL OF STIMULATION OF SUPERULATION | |
| RU2015139515A (en) | COMBINED TREATMENT | |
| CN204502073U (en) | Portable Chinese medicine hemorrhoid treatment device | |
| MX2017010306A (en) | Blockers of the growth hormone receptor in disease prevention and treatment. | |
| McCue | Management of seasonal anestrus: Hormone therapy | |
| Kaunitz et al. | When should a menopausal woman discontinue hormone therapy? | |
| Pincus | Recent Progress in Hormone Research: The Proceedings of the Laurentian Hormone Conference | |
| RU2510284C1 (en) | Method for integrated treatment of pathozoospermia in males suffering adrenal hyperandrogenism | |
| Proietto et al. | Progesterone and estradiol modulate gonadotropin-releasing hormone effect over LH surge in the South American Plains Vizcacha, Lagostomus maximus | |
| Yassen et al. | THE EFFECT OF PALM POLLEN SUPPLEMENT ON SPERM DEVELOPMENT IN IRAQI RAMS | |
| Hilmes | Central Progesterone Involvement in Estrogen-Induced Prolactin and Luteinizing Hormone Secretion Surges in Female Rats | |
| JP2011518136A5 (en) | ||
| Degenstein et al. | Effect of split weaning on hormone release in lactating sows. | |
| Althaqfi et al. | Results of brachytherapy in anal cancer from a cohort of 173 patients treated at the same institution over a 20 year period | |
| Fakheri et al. | Evaluation of lithium chronic effects on thyroid tissues and its secreted hormones in female rats. | |
| Korkmaz et al. | 46, XY Complete Gonadal Dysgenesis: A Case Report | |
| Sasagawa | Pituitary apoplexy: case report | |
| Fabbrocini | EMPACT syndrome: 2 case reports | |
| Gorbunova | Colitis and bilateral abscesses: 2 case reports |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |